M. Furtado, R. Murphy, Steven Wolinsky (1993)
Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy.The Journal of infectious diseases, 167 1
J. Mulder, N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, S. Kwok (1994)
Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infectionJournal of Clinical Microbiology, 32
K. Saksela, C. Stevens, P. Rubinstein, P. Taylor, D. Baltimore (1995)
HIV-1 Messenger RNA in Peripheral Blood Mononuclear Cells as an Early Marker of Risk for Progression to AIDSAnnals of Internal Medicine, 123
T. Chun, L. Stuyver, S. Mizell, L. Ehler, J. Mican, M. Baseler, A. Lloyd, M. Nowak, A. Fauci (1997)
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.Proceedings of the National Academy of Sciences of the United States of America, 94 24
J. Ioannidis, P. Rosenberg, J. Goedert, L. Ashton, T. Benfield, S. Buchbinder, R. Coutinho, J. Eugen-Olsen, T. Gallart, T. Katzenstein, L. Kostrikis, H. Kuipers, L. Louie, S. Mallal, J. Margolick, O. Martinez, L. Meyer, N. Michael, E. Operskalski, G. Pantaleo, G. Rizzardi, H. Schuitemaker, H. Sheppard, G. Stewart, I. Theodorou, H. Ullum, E. Vicenzi, D. Vlahov, D. Wilkinson, C. Workman, J. Zagury, T. O'Brien (2001)
Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient DataAnnals of Internal Medicine, 135
S. O’Brien, John Moore (2000)
The effect of genetic variation in chemokines and their receptorson HIV transmission and progression to AIDSImmunological Reviews, 177
(1998)
Ledergerber, and the Swiss HIV Cohort Study
N. Vandegraaff, Raman Kumar, H. Hocking, T. Burke, J. Mills, D. Rhodes, C. Burrell, Peng Li (2001)
Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 IntegraseAntimicrobial Agents and Chemotherapy, 45
W. O'brien, P. Hartigan, D. Martin, James Esinhart, Andrew Hill, S. Benoit, M. Rubin, M. Simberkoff, J. Hamilton (1996)
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.The New England journal of medicine, 334 7
S. Hammer, Kathleen Squires, M. Hughes, Michael Hughes, J. Grimes, L. Demeter, J. Currier, J. Eron, J. Feinberg, H. Balfour, L. Deyton, J. Chodakewitz, M. Fischl, J. Phair, W. Spreen, L. Pedneault, B. Nguyen, Jon Cook (1997)
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.The New England journal of medicine, 337 11
J. Montoya, R. Wood, D. Katzenstein, M. Holodny, T. Merigan (1993)
Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effectJournal of Clinical Microbiology, 31
T. Chun, A. Fauci (1999)
Latent reservoirs of HIV: obstacles to the eradication of virus.Proceedings of the National Academy of Sciences of the United States of America, 96 20
N. Vandegraaff, Raman Kumar, C. Burrell, Peng Li (2001)
Kinetics of Human Immunodeficiency Virus Type 1 (HIV) DNA Integration in Acutely Infected Cells as Determined Using a Novel Assay for Detection of Integrated HIV DNAJournal of Virology, 75
W. Powderly, M. Saag, S. Chapman, George Yu, B. Quart, N. Clendeninn (1999)
Predictors of optimal virological response to potent antiretroviral therapy.AIDS, 13 14
S. Aoki, R. Yarchoan, R. Thomas, J. Pluda, K. Marczyk, S. Broder, H. Mitsuya (1990)
Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI).AIDS research and human retroviruses, 6 11
J. Levy (1989)
Pathogenesis of human immunodeficiency virus infectionMicrobiological Reviews, 57
M. Eyster, M. Gail, J. Ballard, H. Al-Mondhiry, J. Goedert (1987)
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.Annals of internal medicine, 107 1
Cott, H. M., Ammer, Athleen, S. E., Quires, Ichael, H. D., Ughes, Anet, G. M., Rimes, Isa, D. M., Emeter, Udith, C. S., Urrier, oseph, E. J., Ron, F. E., Einberg, enry, B. H., Alfour, Awrence, D. R., Eyton, Effrey, C. A., Hodakewitz, Argaret, F. A., Ischl (2000)
A CONTROLLED TRIAL OF TWO NUCLEOSIDE ANALOGUES PLUS INDINAVIR IN PERSONS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND CD4 CELL COUNTS OF 200 PER CUBIC MILLIMETER OR LESS
N. Désiré, A. Dehée, V. Schneider, C. Jacomet, C. Goujon, P. Girard, W. Rozenbaum, J. Nicolas (2001)
Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR AssayJournal of Clinical Microbiology, 39
(1996)
Hirsch for the AIDS Clinical Trials Group Study 175 Virology
B. Gemen, R. Beuningen, A. Nabbe, D. Strijp, S. Jurriaans, P. Lens, T. Kievits (1994)
A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.Journal of virological methods, 49 2
D. Finzi, M. Heřmánková, T. Pierson, L. Carruth, C. Buck, R. Chaisson, T. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. Ho, D. Richman, R. Siliciano (1997)
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science, 278 5341
Shizuko Sei, David Kleiner, Jeffrey Kopp, Roma Chandra, P. Klotman, R. Yarchoan, P. Pizzo, Hiroaki Mitsuya (1994)
Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction.The Journal of infectious diseases, 170 2
Thomas Schmittgen (2002)
Real-Time Quantitative PCR
Á. Ibáñez, T. Puig, J. Elias, B. Clotet, L. Ruíz, M. Martínez (1999)
Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.AIDS, 13 9
C. Tamalet, A. Lafeuillade, J. Fantini, C. Poggi, N. Yahi (1997)
Quantification of HIV‐1 viral load in lymphoid and blood cells: assessment during four‐drug combination therapyAIDS, 11
S. Bruisten, P. Reiss, A. Loeliger, P. Swieten, R. Schuurman, C. Boucher, G. Weverling, J. Huisman (1998)
Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.AIDS research and human retroviruses, 14 12
D. Kempf, R. Rode, Yi Xu, E. Sun, M. Heath-Chiozzi, J. Valdes, A. Japour, S. Danner, C. Boucher, A. Molla, J. Leonard (1998)
The duration of viral suppression during protease inhibitor therapy for HIV‐1 infection is predicted by plasma HIV‐1 RNA at the nadirAIDS, 12
M. Sharkey, I. Teo, T. Greenough, N. Sharova, K. Luzuriaga, J. Sullivan, R. Bucy, L. Kostrikis, A. Haase, C. Veryard, R. Davaro, S. Cheeseman, J. Daly, C. Bova, R. Ellison, B. Mady, Kwan Lai, G. Moyle, M. Nelson, B. Gazzard, S. Shaunak, M. Stevenson (2000)
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapyNature Medicine, 6
(2001)
Rouzioux for the French PRIMO Cohort Study Group
J. Wong, H. Günthard, D. Havlir, Zhi Zhang, A. Haase, C. Ignacio, S. Kwok, E. Emini, D. Richman (1997)
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.Proceedings of the National Academy of Sciences of the United States of America, 94 23
R. Cone, P. Gowland, M. Opravil, P. Grob, B. Ledergerber (1998)
Levels of HIV‐infected peripheral blood cells remain stable throughout the natural history of HIV‐1 infectionAIDS, 12
Sanjay Tyagi, F. Kramer (1996)
Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 14
G. Pantaleo, C. Graziosi, A. Fauci (1993)
The immunopathogenesis of human immunodeficiency virus infection.The New England journal of medicine, 328 5
(2001)
Kostrikis for the Multicenter Hemophilia Cohort Study
M. Vesanen, C. Stevens, P. Taylor, P. Rubinstein, K. Saksela (1996)
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected personsJournal of Virology, 70
P. Bieniasz, K. Ariyoshi, Michel Bourelly, S. Bloor, R. Foxall, E. Harwood, J. Weber (1993)
Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV‐1‐infected individualsAIDS, 7
F. Mallet, C. Hebrard, J. Livrozet, O. Lees, F. Tron, J. Touraine, B. Mandrand (1995)
Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assayJournal of Clinical Microbiology, 33
J. Mellors, L. Kingsley, C. Rinaldo, J. Todd, B. Hoo, Robert Kokka, Phalguni Gupta (1995)
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 122
R. Gulick, J. Mellors, D. Havlir, J. Eron, C. González, D. McMahon, D. Richman, F. Valentine, L. Jonas, A. Meibohm, E. Emini, J. Chodakewitz (1997)
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.The New England journal of medicine, 337 11
T. Chun, L. Carruth, D. Finzi, Xuefei Shen, Joseph DiGiuseppe, H. Taylor, M. Heřmánková, K. Chadwick, J. Margolick, T. Quinn, Y. Kuo, R. Brookmeyer, M. Zeiger, P. Barditch‐Crovo, R. Siliciano (1997)
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 387
(1995)
New Concepts...Cornell Hotel and Restaurant Administration Quarterly, 36
P. Gupta, M. Ding, M. Cottrill, C. Rinaldo, L. Kingsley, Steven Wolinsky, J. Mellors (1995)
Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assayJournal of Clinical Microbiology, 33
S. Menzo, P. Bagnarelli, M. Giacca, A. Manzin, P. Varaldo, M. Clementi (1992)
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reactionJournal of Clinical Microbiology, 30
S. Yerly, L. Kaiser, C. Baumberger, B. Hirschel, L. Perrin (1995)
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 8 4
R. Dewar, Helene Highbarger, M. Sarmiento, John Todd, M. Vasudevachari, R. Davey, J. Kovacs, N. Salzman, H. Lane, M. Urdea (1994)
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma.The Journal of infectious diseases, 170 5
L. Kostrikis, A. Neumann, B. Thomson, B. Korber, P. McHardy, R. Karanicolas, L. Deutsch, Y. Huang, J. Lew, K. Mcintosh, H. Pollack, W. Borkowsky, H. Spiegel, P. Palumbo, J. Oleske, A. Bardeguez, K. Luzuriaga, J. Sullivan, Steven Wolinsky, R. Koup, D. Ho, J. Moore (1999)
A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American InfantsJournal of Virology, 73
Wei-Shau Hu, H. Temin (1990)
Retroviral recombination and reverse transcription.Science, 250 4985
S. Butler, M. Hansen, F. Bushman (2001)
A quantitative assay for HIV DNA integration in vivoNature Medicine, 7
T. Chun, D. Engel, M. Berrey, T. Shea, L. Corey, A. Fauci (1998)
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.Proceedings of the National Academy of Sciences of the United States of America, 95 15
M. Hughes, V. Johnson, M. Hirsch, J. Bremer, T. Elbeik, A. Erice, D. Kuritzkes, W. Scott, S. Spector, N. Basgoz, M. Fischl, R. D’Aquila (1997)
Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic ResponseAnnals of Internal Medicine, 126
L. Kostrikis, Sanjay Tyagi, M. Mhlanga, D. Ho, F. Kramer (1998)
Spectral Genotyping of Human AllelesScience, 279
J. Wong, M. Hezareh, H. Günthard, D. Havlir, C. Ignacio, C. Spina, D. Richman (1997)
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science, 278 5341
J. Goedert, T. O'Brien, A. Hatzakis, L. Kostrikis (2001)
T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapyAIDS, 15
M. Furtado, D. Callaway, J. Phair, K. Kunstman, J. Stanton, C. Macken, A. Perelson, Steven Wolinsky (1999)
Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.The New England journal of medicine, 340 21
R. Pomerantz (1999)
Residual HIV-1 disease in the era of highly active antiretroviral therapy.The New England journal of medicine, 340 21
G. Touloumi, A. Karafoulidou, A. Gialeraki, O. Katsarou, Ioanna Milona, V. Kapsimali, Titika Mandalaki, A. Hatzakis (1998)
Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 19 1
A. Valentin, H. Trivedi, W. Lu, L. Kostrikis, G. Pavlakis (2000)
CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages.Virology, 269 2
Michael Polis, I. Sidorov, C. Yoder, S. Jankelevich, J. Metcalf, B. Mueller, MA Dimitrov, P. Pizzo, R. Yarchoan, D. Dimitrov (2001)
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacyThe Lancet, 358
J. Mellors, C. Rinaldo, Phalguni Gupta, R. White, J. Todd, L. Kingsley (1996)
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 272
Stephen O'Brien, G. Nelson, Cheryl Winkler, Michael Smith (2000)
Polygenic and multifactorial disease gene association in man: Lessons from AIDS.Annual review of genetics, 34
W. O’Brien, P. Hartigan, E. Daar, M. Simberkoff, J. Hamilton (1997)
Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic FailureAnnals of Internal Medicine, 126
Phalguni Gupta, L. Kingsley, John Armstrong, Ming Ding, Martin Cottrill, C. Rinaldo (1993)
Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.Virology, 196 2
C. Christopherson, Yorda Kidane, B. Conway, J. Krowka, H. Sheppard, S. Kwok (2000)
PCR-Based Assay To Quantify Human Immunodeficiency Virus Type 1 DNA in Peripheral Blood Mononuclear CellsJournal of Clinical Microbiology, 38
D. Katzenstein, S. Hammer, M. Hughes, H. Gundacker, J. Jackson, S. Fiscus, S. Rasheed, T. Elbeik, R. Reichman, A. Japour, T. Merigan, M. Hirsch (1996)
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.The New England journal of medicine, 335 15
H. Ioachim (1990)
Immunopathogenesis of human immunodeficiency virus infection.Cancer research, 50 17 Suppl
L. Kostrikis, Yaoxing Huang, John Moore, Steven Wolinsky, Linqi Zhang, Yong Guo, L. Deutsch, J. Phair, A. Neumann, D. Ho (1998)
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationNature Medicine, 4
N. Ngo-Giang-Huong, C. Deveau, I. Silva, I. Pellegrin, A. Venet, M. Harzic, M. Sinet, J. Delfraissy, L. Meyer, C. Goujard, C. Rouzioux (2001)
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapyAIDS, 15
A. Hatzakis, G. Touloumi, R. Karanicolas, A. Karafoulidou, T. Mandalaki, C. Anastassopoulou, Linqi Zhang, J. Goedert, D. Ho, L. Kostrikis (2000)
Effect of recent thymic emigrants on progression of HIV-1 diseaseThe Lancet, 355
J. Izopet, C. Tamalet, C. Pasquier, K. Sandres, B. Marchou, P. Massip, J. Puel (1998)
Quantification of HIV‐1 proviral DNA by a standardized colorimetric PCR‐based assayJournal of Medical Virology, 54
Hui Zhang, G. Dornadula, M. Beumont, L. Livornese, B. Uitert, K. Henning, R. Pomerantz (1998)
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.The New England journal of medicine, 339 25
H. Lin, M. Haywood, F. Hollinger (1996)
Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNAJournal of Clinical Microbiology, 34
T. O'Brien, W. Blattner, D. Waters, M. Eyster, M. Hilgartner, Alan Cohen, N. Luban, A. Hatzakis, L. Aledort, P. Rosenberg, W. Miley, B. Kroner, J. Goedert (1996)
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.JAMA, 276 2
Journal of Virology – Unpaywall
Published: Sep 18, 2002
Access the full text.
Sign up today, get DeepDyve free for 14 days.